Israel mulls criminal action against firm for failing to report changes to thyroid drug Eltroxin
Perrigo company, which markets the Eltroxin drug in Israel, relayed an incorrect report to the Health Ministry about changes in the composition of the thyroid medication, according to the documents.
After hundreds of users lodged complaints about side effects resulting from changes in the composition of the drug, the Eltroxin affair has taken a dramatic turn.
register with haaretz
Like us on Facebook and get articles directly in your news feed